Activation of primary human chronic lymphocytic leukemia (cll) cells by interleukin-2 (il-2): implications for cancer vaccine development

Michael J. Robertson, Kristen Ganjoo, Lynette Timmons

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Activation of primary human chronic lymphocytic leukemia (cll) cells by interleukin-2 (il-2): implications for cancer vaccine development'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences